Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. https://doi.org/10.1002/ijc.29210.
Google Scholar
Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246(5):693–701. https://doi.org/10.1097/01.sla.0000257358.56863.ce.
Google Scholar
van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12(6):575–82. https://doi.org/10.1016/S1470-2045(11)70097-3.
Google Scholar
Beppu N, Kimura F, Aihara T, Doi H, Tomita N, Yanagi H, et al. Patterns of local recurrence and oncologic outcomes in T3 low rectal cancer (≤5 cm from the anal verge) treated with short-course radiotherapy with delayed surgery : outcomes in T3 low rectal cancer treated with short-course radiotherapy with delayed surgery. Ann Surg Oncol. 2017;24(1):219–26. https://doi.org/10.1245/s10434-016-5604-6.
Google Scholar
Pacelli F, Tortorelli AP, Rosa F, Bossola M, Sanchez AM, Papa V, et al. Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy. Ann Surg Oncol. 2010;17(1):152–62. https://doi.org/10.1245/s10434-009-0737-5.
Google Scholar
Kanemitsu Y, Hirai T, Komori K, Kato T. Prediction of residual disease or distant metastasis after resection of locally recurrent rectal cancer. Dis Colon Rectum. 2010;53(5):779–89. https://doi.org/10.1007/DCR.0b013e3181cf7609.
Google Scholar
Harris CA, Solomon MJ, Heriot AG, Sagar PM, Tekkis PP, Dixon L, et al. The outcomes and patterns of treatment failure after surgery for locally recurrent rectal Cancer. Ann Surg. 2016;264(2):323–9. https://doi.org/10.1097/SLA.0000000000001524.
Google Scholar
Uemura M, Ikeda M, Yamamoto H, Kitani K, Tokuoka M, Matsuda K, et al. Clinicopathological assessment of locally recurrent rectal cancer and relation to local re-recurrence. Ann Surg Oncol. 2011;18(4):1015–22. https://doi.org/10.1245/s10434-010-1435-z.
Google Scholar
Dresen RC, Gosens MJ, Martijn H, Nieuwenhuijzen GA, Creemers GJ, Daniels-Gooszen AW, et al. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol. 2008;15(7):1937–47. https://doi.org/10.1245/s10434-008-9896-z.
Google Scholar
Asoglu O, Karanlik H, Muslumanoglu M, Igci A, Emek E, Ozmen V, et al. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol. 2007;33(10):1199–206. https://doi.org/10.1016/j.ejso.2007.02.026.
Google Scholar
Palmer G, Martling A, Cedermark B, Holm T. A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol. 2007;14(2):447–54. https://doi.org/10.1245/s10434-006-9256-9.
Google Scholar
Uemura M, Ikeda M, Sekimoto M, Haraguchi N, Mizushima T, Yamamoto H, et al. Prevention of severe pelvic abscess formation following extended radical surgery for locally recurrent rectal cancer. Ann Surg Oncol. 2009;16(8):2204–10. https://doi.org/10.1245/s10434-009-0505-6.
Google Scholar
Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, Vera-Badillo FE, Hermanns T, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2014;23(7):1204–12. https://doi.org/10.1158/1055-9965.EPI-14-0146.
Google Scholar
Choi WJ, Cleghorn MC, Jiang H, Jackson TD, Okrainec A, Quereshy FA. Preoperative neutrophil-to-lymphocyte ratio is a better prognostic serum biomarker than platelet-to-lymphocyte ratio in patients undergoing resection for nonmetastatic colorectal cancer. Ann Surg Oncol. 2015;22(Suppl 3):S603–13.
Google Scholar
Shibutani M, Maeda K, Nagahara H, Iseki Y, Ikeya T, Hirakawa K. Prognostic significance of the preoperative ratio of C-reactive protein to albumin in patients with colorectal cancer. Anticancer Res. 2016;36(3):995–1001.
Google Scholar
Mohri Y, Inoue Y, Tanaka K, Hiro J, Uchida K, Kusunoki M. Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World J Surg. 2013;37(11):2688–92. https://doi.org/10.1007/s00268-013-2156-9.
Google Scholar
Aoyama T, Oba K, Honda M, Sadahiro S, Hamada C, Mayanagi S, et al. Impact of postoperative complications on the colorectal cancer survival and recurrence: analyses of pooled individual patients' data from three large phase III randomized trials. Cancer Med. 2017;6(7):1573–80. https://doi.org/10.1002/cam4.1126.
Google Scholar
Okada S, Shimada J, Teramukai S, Kato D, Tsunezuka H, Miyata N, et al. Risk stratification according to the prognostic nutritional index for predicting postoperative complications after lung cancer surgery. Ann Surg Oncol. 2018;25(5):1254–61. https://doi.org/10.1245/s10434-018-6368-y.
Google Scholar
Kanda M, Fujii T, Kodera Y, Nagai S, Takeda S, Nakao A. Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg. 2011;98(2):268–74. https://doi.org/10.1002/bjs.7305.
Google Scholar
Egenvall M, Mörner M, Påhlman L, Gunnarsson U. Degree of blood loss during surgery for rectal cancer: a population-based epidemiologic study of surgical complications and survival. Color Dis. 2014;16(9):696–702. https://doi.org/10.1111/codi.12630.
Google Scholar
Mörner ME, Gunnarsson U, Jestin P, Svanfeldt M. The importance of blood loss during colon cancer surgery for long-term survival: an epidemiological study based on a population based register. Ann Surg. 2012;255(6):1126–8. https://doi.org/10.1097/SLA.0b013e3182512df0.
Google Scholar
Pak J, Ikeda M, Uemura M, Miyake M, Nishikawa K, Miyamoto A, et al. Risk factors for bleeding in patients receiving fondaparinux after colorectal cancer surgery. J Anus Rectum Colon. 2018;1(4):131–5. https://doi.org/10.23922/jarc.2017-022.
Google Scholar
Yamaoka Y, Ikeda M, Ikenaga M, Haraguchi N, Miyake M, Sekimoto M. Safety and efficacy of fondaparinux for prophylaxis of venous thromboembolism after colorectal cancer resection: a propensity score matched analysis. Dig Surg. 2015;32(3):190–5. https://doi.org/10.1159/000381034.
Google Scholar
Hata K, Kimura T, Tsuzuki S, Ishii G, Kido M, Yamamoto T, et al. Safety of fondaparinux for prevention of postoperative venous thromboembolism in urological malignancy: a prospective randomized clinical trial. Int J Urol. 2016;23(11):923–8. https://doi.org/10.1111/iju.13189.
Google Scholar
Yamamoto K, Nagatsuma Y, Fukuda Y, Hirao M, Nishikawa K, Miyamoto A, et al. Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancer. Gastric Cancer. 2017;20(5):913–8. https://doi.org/10.1007/s10120-016-0683-4.
Google Scholar
Uemura M, Ikeda M, Kawai K, Nishimura J, Takemasa I, Mizushima T, et al. Laparoscopic surgery using a Gigli wire saw for locally recurrent rectal cancer with concomitant intraperitoneal sacrectomy. Asian J Endosc Surg. 2018;11(1):83–6. https://doi.org/10.1111/ases.12407.
Google Scholar
Kennedy RH, Francis EA, Wharton R, Blazeby JM, Quirke P, West NP, et al. Multicenter randomized controlled trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programme: EnROL. J Clin Oncol. 2014;32(17):1804–11. https://doi.org/10.1200/JCO.2013.54.3694.
Google Scholar
van der Pas MH, Haglind E, Cuesta MA, Fürst A, Lacy AM, Hop WC, et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013;14(3):210–8. https://doi.org/10.1016/S1470-2045(13)70016-0.
Google Scholar